NMI TT Pharmaservices

NMI TT is a specialized, full-service CRO and microdevice developer based in Reutlingen, Germany, with roots in the University of Tübingen's Natural and Medical Sciences Institute. Its core value proposition is the integration of three business units: contract research services (protein profiling, cell-based assays, electrophysiology), GMP testing, and the development of proprietary microdevice platforms like Microelectrode Arrays (MEA) and ZeptoCHIP arrays. This integrated model allows the company to serve as a critical partner for clients in drug discovery and development, particularly in complex areas requiring specialized electrophysiology and micro-scale analytical solutions. As a private, revenue-generating entity, it leverages its academic heritage to offer tailored, cutting-edge services to the life sciences industry.

Proprietary microdevice platforms including Microelectrode Arrays (MEA) for electrophysiology and ZeptoCHIP arrays for protein profiling, integrated with contract research and GMP testing services.

NMI TT competes with large, full-service CROs (e.g., LabCorp, IQVIA) on specialized service lines and with specialized electrophysiology/device firms (e.g., Axion BioSystems, Maxwell Biosystems). Its key differentiator is the vertical integration of custom microdevice fabrication with biological testing services, a niche not fully addressed by larger, less agile competitors.